Reuters examines investors' interests in bonds that support GAVI Alliance

NewsGuard 100/100 Score

"It's not only biologists, philanthropists and donor governments who are needed to make vaccine projects in poor countries work. Financial engineers … also have a role," Reuters writes in an article that examines how "a new kind of bond issue" is helping to support the GAVI Alliance.

"Designed to roll forward future donor pledges into cash-in-hand today, the idea was pioneered in 2005 by Gordon Brown, then British finance minister," and the "$1 billion bond from the International Finance Facility for Immunisation (IFFIm) was launched in 2006 to mature in November 2011," the news service writes. "The bonds have struck a chord with institutional investors who appreciate the steady returns and AAA rating of notes on which the World Bank acts as treasurer."

Gary Smith, a banker, who Reuters writes, "helped set up a sterling offering for HSBC [Bank]," said, "It's not a donation; it's an investment. But the mechanics of the product mean the money gets to GAVI sooner and that means immunisations can start sooner."

The article details additional features of the bonds that attract investors before noting, "IFFIm's bonds are backed by the governments of Britain, France, Italy, Norway, Spain, the Netherlands, Sweden and South Africa, which have pledged a total of $5.9 billion to fund vaccines in the developing world over 23 years" (Hirschler, 12/14).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Oral spray-based vaccine is a potential alternative to antibiotic treatments for recurrent UTIs